Pinealon: what it is and what the evidence says
A short peptide (bioregulator family) studied for its relationship with neuronal function and cognitive protection.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
The brain adapts by forming and strengthening connections. Neurotransmitters take part in that conversation, along with factors that help neurons survive and grow. Compounds in this group are studied for their relationship with focus, memory, mood or neuroprotection — and it is worth saying plainly that this is the area where claims are most exaggerated and where human evidence is thinnest.
What it is studied for
Focus, cognitive protection.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
There are no randomized clinical trials: the only publication in people is a Russian open-label study in patients with multiple coexisting conditions, with no placebo group and no independent verification.
The limitation that matters most
Practically all the literature comes from a single Russian group in low-impact journals; several papers do not even study Pinealon on its own, but mixtures of short peptides.
Regulatory status
Not approved outside Russia.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
Mostly preliminary evidence; variable individual response.
With neurological conditions, prioritize professional assessment.
What this page cannot give you
A reference page can take you this far. You know what Pinealon is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processespreclinical Rejuvenation Res · 2011 · PMID 21978084 →
- Pinealon protects the rat offspring from prenatal hyperhomocysteinemiapreclinical Int J Clin Exp Med · 2012 · PMID 22567179 →
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNApreclinical Biochemistry (Mosc) · 2011 · PMID 22117547 →
- Short peptides stimulate serotonin expression in cells of brain cortexpreclinical Bull Exp Biol Med · 2014 · PMID 24909721 →
- [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]human Adv Gerontol · 2015 · PMID 26390612 →
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Diseasereview Molecules · 2020 · PMID 33396470 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Pinealon or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Pinealon?
A short peptide (bioregulator family) studied for its relationship with neuronal function and cognitive protection. It is studied within the area of cognitive.
Is there human evidence for Pinealon?
There are no randomized clinical trials: the only publication in people is a Russian open-label study in patients with multiple coexisting conditions, with no placebo group and no independent verification.
Is it approved by any health agency?
Not approved outside Russia.
What is the dose of Pinealon?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Pinealon is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.